Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial

Overview of attention for article published in Journal of Antimicrobial Chemotherapy (JAC), May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

blogs: 1 blog

twitter: 3 X users

Citations

dimensions_citation: 68 Dimensions

Readers on

mendeley: 85 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 52,291 followers.

@GideonStitt @PhxChildrens @SIDPharm @IDPharmacometrx @KevinJDownes @DosingMatters @IDpharmresearch @Crasspofungin @jasonroberts_pk @BAMPharmD @IDPLab @ShaerPKPD There are guidelines from the French here: https://t.co/3Hp1FBl68l Only two RCTs are availabl

Reply Repost Favourite

Do doses of piperacillin/tazobactam offer adequate exposure in febrile #neutropenic patients? http://t.co/Pj2zsRTy5I @BSACandJAC

Reply Repost Favourite

Can #TDM optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? An RCT http://t.co/rCXlAng8DK

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.